The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diabetes Lancing Devices Market Research Report 2025
Synopsis
Diabetes Lancing Devices, also known as lancets, are medical devices used by people with diabetes to obtain a small blood sample for blood glucose testing. These devices typically consist of a sharp, spring-loaded needle that is used to prick the fingertip, allowing the user to measure their blood sugar levels using a glucose meter.
The global Diabetes Lancing Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Diabetes Lancing Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Lancing Devices.
Report Scope
The Diabetes Lancing Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetes Lancing Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Lancing Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
LifeScan
Abbott
Ascensia
B. Braun
Terumo
ARKRAY
Trividia Health
SANNUO
GMMC
BIONIME
Segment by Type
Adjustable Lancing Device
Non-adjustable Lancing Device
Segment by Application
Household
Commercial
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diabetes Lancing Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diabetes Lancing Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Diabetes Lancing Devices, also known as lancets, are medical devices used by people with diabetes to obtain a small blood sample for blood glucose testing. These devices typically consist of a sharp, spring-loaded needle that is used to prick the fingertip, allowing the user to measure their blood sugar levels using a glucose meter.
The global Diabetes Lancing Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Diabetes Lancing Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Lancing Devices.
Report Scope
The Diabetes Lancing Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetes Lancing Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Lancing Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
LifeScan
Abbott
Ascensia
B. Braun
Terumo
ARKRAY
Trividia Health
SANNUO
GMMC
BIONIME
Segment by Type
Adjustable Lancing Device
Non-adjustable Lancing Device
Segment by Application
Household
Commercial
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diabetes Lancing Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diabetes Lancing Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Diabetes Lancing Devices Market Overview
1.1 Product Overview and Scope of Diabetes Lancing Devices
1.2 Diabetes Lancing Devices Segment by Type
1.2.1 Global Diabetes Lancing Devices Market Value Comparison by Type (2024-2030)
1.2.2 Adjustable Lancing Device
1.2.3 Non-adjustable Lancing Device
1.3 Diabetes Lancing Devices Segment by Application
1.3.1 Global Diabetes Lancing Devices Market Value by Application: (2024-2030)
1.3.2 Household
1.3.3 Commercial
1.4 Global Diabetes Lancing Devices Market Size Estimates and Forecasts
1.4.1 Global Diabetes Lancing Devices Revenue 2019-2030
1.4.2 Global Diabetes Lancing Devices Sales 2019-2030
1.4.3 Global Diabetes Lancing Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diabetes Lancing Devices Market Competition by Manufacturers
2.1 Global Diabetes Lancing Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diabetes Lancing Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diabetes Lancing Devices Average Price by Manufacturers (2019-2024)
2.4 Global Diabetes Lancing Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diabetes Lancing Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diabetes Lancing Devices, Product Type & Application
2.7 Diabetes Lancing Devices Market Competitive Situation and Trends
2.7.1 Diabetes Lancing Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diabetes Lancing Devices Players Market Share by Revenue
2.7.3 Global Diabetes Lancing Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diabetes Lancing Devices Retrospective Market Scenario by Region
3.1 Global Diabetes Lancing Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diabetes Lancing Devices Global Diabetes Lancing Devices Sales by Region: 2019-2030
3.2.1 Global Diabetes Lancing Devices Sales by Region: 2019-2024
3.2.2 Global Diabetes Lancing Devices Sales by Region: 2025-2030
3.3 Global Diabetes Lancing Devices Global Diabetes Lancing Devices Revenue by Region: 2019-2030
3.3.1 Global Diabetes Lancing Devices Revenue by Region: 2019-2024
3.3.2 Global Diabetes Lancing Devices Revenue by Region: 2025-2030
3.4 North America Diabetes Lancing Devices Market Facts & Figures by Country
3.4.1 North America Diabetes Lancing Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diabetes Lancing Devices Sales by Country (2019-2030)
3.4.3 North America Diabetes Lancing Devices Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Diabetes Lancing Devices Market Facts & Figures by Country
3.5.1 Europe Diabetes Lancing Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diabetes Lancing Devices Sales by Country (2019-2030)
3.5.3 Europe Diabetes Lancing Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diabetes Lancing Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Diabetes Lancing Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diabetes Lancing Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Diabetes Lancing Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Diabetes Lancing Devices Market Facts & Figures by Country
3.7.1 Latin America Diabetes Lancing Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diabetes Lancing Devices Sales by Country (2019-2030)
3.7.3 Latin America Diabetes Lancing Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diabetes Lancing Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Diabetes Lancing Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diabetes Lancing Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diabetes Lancing Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diabetes Lancing Devices Sales by Type (2019-2030)
4.1.1 Global Diabetes Lancing Devices Sales by Type (2019-2024)
4.1.2 Global Diabetes Lancing Devices Sales by Type (2025-2030)
4.1.3 Global Diabetes Lancing Devices Sales Market Share by Type (2019-2030)
4.2 Global Diabetes Lancing Devices Revenue by Type (2019-2030)
4.2.1 Global Diabetes Lancing Devices Revenue by Type (2019-2024)
4.2.2 Global Diabetes Lancing Devices Revenue by Type (2025-2030)
4.2.3 Global Diabetes Lancing Devices Revenue Market Share by Type (2019-2030)
4.3 Global Diabetes Lancing Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diabetes Lancing Devices Sales by Application (2019-2030)
5.1.1 Global Diabetes Lancing Devices Sales by Application (2019-2024)
5.1.2 Global Diabetes Lancing Devices Sales by Application (2025-2030)
5.1.3 Global Diabetes Lancing Devices Sales Market Share by Application (2019-2030)
5.2 Global Diabetes Lancing Devices Revenue by Application (2019-2030)
5.2.1 Global Diabetes Lancing Devices Revenue by Application (2019-2024)
5.2.2 Global Diabetes Lancing Devices Revenue by Application (2025-2030)
5.2.3 Global Diabetes Lancing Devices Revenue Market Share by Application (2019-2030)
5.3 Global Diabetes Lancing Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Diabetes Lancing Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Diabetes Lancing Devices Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 LifeScan
6.2.1 LifeScan Corporation Information
6.2.2 LifeScan Description and Business Overview
6.2.3 LifeScan Diabetes Lancing Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 LifeScan Diabetes Lancing Devices Product Portfolio
6.2.5 LifeScan Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Diabetes Lancing Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Diabetes Lancing Devices Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Ascensia
6.4.1 Ascensia Corporation Information
6.4.2 Ascensia Description and Business Overview
6.4.3 Ascensia Diabetes Lancing Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ascensia Diabetes Lancing Devices Product Portfolio
6.4.5 Ascensia Recent Developments/Updates
6.5 B. Braun
6.5.1 B. Braun Corporation Information
6.5.2 B. Braun Description and Business Overview
6.5.3 B. Braun Diabetes Lancing Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 B. Braun Diabetes Lancing Devices Product Portfolio
6.5.5 B. Braun Recent Developments/Updates
6.6 Terumo
6.6.1 Terumo Corporation Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo Diabetes Lancing Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Terumo Diabetes Lancing Devices Product Portfolio
6.6.5 Terumo Recent Developments/Updates
6.7 ARKRAY
6.6.1 ARKRAY Corporation Information
6.6.2 ARKRAY Description and Business Overview
6.6.3 ARKRAY Diabetes Lancing Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ARKRAY Diabetes Lancing Devices Product Portfolio
6.7.5 ARKRAY Recent Developments/Updates
6.8 Trividia Health
6.8.1 Trividia Health Corporation Information
6.8.2 Trividia Health Description and Business Overview
6.8.3 Trividia Health Diabetes Lancing Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Trividia Health Diabetes Lancing Devices Product Portfolio
6.8.5 Trividia Health Recent Developments/Updates
6.9 SANNUO
6.9.1 SANNUO Corporation Information
6.9.2 SANNUO Description and Business Overview
6.9.3 SANNUO Diabetes Lancing Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SANNUO Diabetes Lancing Devices Product Portfolio
6.9.5 SANNUO Recent Developments/Updates
6.10 GMMC
6.10.1 GMMC Corporation Information
6.10.2 GMMC Description and Business Overview
6.10.3 GMMC Diabetes Lancing Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GMMC Diabetes Lancing Devices Product Portfolio
6.10.5 GMMC Recent Developments/Updates
6.11 BIONIME
6.11.1 BIONIME Corporation Information
6.11.2 BIONIME Diabetes Lancing Devices Description and Business Overview
6.11.3 BIONIME Diabetes Lancing Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 BIONIME Diabetes Lancing Devices Product Portfolio
6.11.5 BIONIME Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diabetes Lancing Devices Industry Chain Analysis
7.2 Diabetes Lancing Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diabetes Lancing Devices Production Mode & Process
7.4 Diabetes Lancing Devices Sales and Marketing
7.4.1 Diabetes Lancing Devices Sales Channels
7.4.2 Diabetes Lancing Devices Distributors
7.5 Diabetes Lancing Devices Customers
8 Diabetes Lancing Devices Market Dynamics
8.1 Diabetes Lancing Devices Industry Trends
8.2 Diabetes Lancing Devices Market Drivers
8.3 Diabetes Lancing Devices Market Challenges
8.4 Diabetes Lancing Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Diabetes Lancing Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Diabetes Lancing Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Diabetes Lancing Devices Market Competitive Situation by Manufacturers in 2023
Table 4. Global Diabetes Lancing Devices Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Diabetes Lancing Devices Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Diabetes Lancing Devices Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Diabetes Lancing Devices Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Diabetes Lancing Devices Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Diabetes Lancing Devices, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Diabetes Lancing Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Diabetes Lancing Devices, Product Type & Application
Table 12. Global Key Manufacturers of Diabetes Lancing Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Diabetes Lancing Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Lancing Devices as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Diabetes Lancing Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Diabetes Lancing Devices Sales by Region (2019-2024) & (K Units)
Table 18. Global Diabetes Lancing Devices Sales Market Share by Region (2019-2024)
Table 19. Global Diabetes Lancing Devices Sales by Region (2025-2030) & (K Units)
Table 20. Global Diabetes Lancing Devices Sales Market Share by Region (2025-2030)
Table 21. Global Diabetes Lancing Devices Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Diabetes Lancing Devices Revenue Market Share by Region (2019-2024)
Table 23. Global Diabetes Lancing Devices Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Diabetes Lancing Devices Revenue Market Share by Region (2025-2030)
Table 25. North America Diabetes Lancing Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Diabetes Lancing Devices Sales by Country (2019-2024) & (K Units)
Table 27. North America Diabetes Lancing Devices Sales by Country (2025-2030) & (K Units)
Table 28. North America Diabetes Lancing Devices Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Diabetes Lancing Devices Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Diabetes Lancing Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Diabetes Lancing Devices Sales by Country (2019-2024) & (K Units)
Table 32. Europe Diabetes Lancing Devices Sales by Country (2025-2030) & (K Units)
Table 33. Europe Diabetes Lancing Devices Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Diabetes Lancing Devices Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Diabetes Lancing Devices Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Diabetes Lancing Devices Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Diabetes Lancing Devices Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Diabetes Lancing Devices Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Diabetes Lancing Devices Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Diabetes Lancing Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Diabetes Lancing Devices Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Diabetes Lancing Devices Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Diabetes Lancing Devices Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Diabetes Lancing Devices Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Diabetes Lancing Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Diabetes Lancing Devices Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Diabetes Lancing Devices Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Diabetes Lancing Devices Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Diabetes Lancing Devices Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Diabetes Lancing Devices Sales (K Units) by Type (2019-2024)
Table 51. Global Diabetes Lancing Devices Sales (K Units) by Type (2025-2030)
Table 52. Global Diabetes Lancing Devices Sales Market Share by Type (2019-2024)
Table 53. Global Diabetes Lancing Devices Sales Market Share by Type (2025-2030)
Table 54. Global Diabetes Lancing Devices Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Diabetes Lancing Devices Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Diabetes Lancing Devices Revenue Market Share by Type (2019-2024)
Table 57. Global Diabetes Lancing Devices Revenue Market Share by Type (2025-2030)
Table 58. Global Diabetes Lancing Devices Price (US$/Unit) by Type (2019-2024)
Table 59. Global Diabetes Lancing Devices Price (US$/Unit) by Type (2025-2030)
Table 60. Global Diabetes Lancing Devices Sales (K Units) by Application (2019-2024)
Table 61. Global Diabetes Lancing Devices Sales (K Units) by Application (2025-2030)
Table 62. Global Diabetes Lancing Devices Sales Market Share by Application (2019-2024)
Table 63. Global Diabetes Lancing Devices Sales Market Share by Application (2025-2030)
Table 64. Global Diabetes Lancing Devices Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Diabetes Lancing Devices Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Diabetes Lancing Devices Revenue Market Share by Application (2019-2024)
Table 67. Global Diabetes Lancing Devices Revenue Market Share by Application (2025-2030)
Table 68. Global Diabetes Lancing Devices Price (US$/Unit) by Application (2019-2024)
Table 69. Global Diabetes Lancing Devices Price (US$/Unit) by Application (2025-2030)
Table 70. Roche Corporation Information
Table 71. Roche Description and Business Overview
Table 72. Roche Diabetes Lancing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Roche Diabetes Lancing Devices Product
Table 74. Roche Recent Developments/Updates
Table 75. LifeScan Corporation Information
Table 76. LifeScan Description and Business Overview
Table 77. LifeScan Diabetes Lancing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. LifeScan Diabetes Lancing Devices Product
Table 79. LifeScan Recent Developments/Updates
Table 80. Abbott Corporation Information
Table 81. Abbott Description and Business Overview
Table 82. Abbott Diabetes Lancing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Abbott Diabetes Lancing Devices Product
Table 84. Abbott Recent Developments/Updates
Table 85. Ascensia Corporation Information
Table 86. Ascensia Description and Business Overview
Table 87. Ascensia Diabetes Lancing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Ascensia Diabetes Lancing Devices Product
Table 89. Ascensia Recent Developments/Updates
Table 90. B. Braun Corporation Information
Table 91. B. Braun Description and Business Overview
Table 92. B. Braun Diabetes Lancing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. B. Braun Diabetes Lancing Devices Product
Table 94. B. Braun Recent Developments/Updates
Table 95. Terumo Corporation Information
Table 96. Terumo Description and Business Overview
Table 97. Terumo Diabetes Lancing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Terumo Diabetes Lancing Devices Product
Table 99. Terumo Recent Developments/Updates
Table 100. ARKRAY Corporation Information
Table 101. ARKRAY Description and Business Overview
Table 102. ARKRAY Diabetes Lancing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. ARKRAY Diabetes Lancing Devices Product
Table 104. ARKRAY Recent Developments/Updates
Table 105. Trividia Health Corporation Information
Table 106. Trividia Health Description and Business Overview
Table 107. Trividia Health Diabetes Lancing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Trividia Health Diabetes Lancing Devices Product
Table 109. Trividia Health Recent Developments/Updates
Table 110. SANNUO Corporation Information
Table 111. SANNUO Description and Business Overview
Table 112. SANNUO Diabetes Lancing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. SANNUO Diabetes Lancing Devices Product
Table 114. SANNUO Recent Developments/Updates
Table 115. GMMC Corporation Information
Table 116. GMMC Description and Business Overview
Table 117. GMMC Diabetes Lancing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. GMMC Diabetes Lancing Devices Product
Table 119. GMMC Recent Developments/Updates
Table 120. BIONIME Corporation Information
Table 121. BIONIME Description and Business Overview
Table 122. BIONIME Diabetes Lancing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. BIONIME Diabetes Lancing Devices Product
Table 124. BIONIME Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Diabetes Lancing Devices Distributors List
Table 128. Diabetes Lancing Devices Customers List
Table 129. Diabetes Lancing Devices Market Trends
Table 130. Diabetes Lancing Devices Market Drivers
Table 131. Diabetes Lancing Devices Market Challenges
Table 132. Diabetes Lancing Devices Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Diabetes Lancing Devices
Figure 2. Global Diabetes Lancing Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Diabetes Lancing Devices Market Share by Type in 2023 & 2030
Figure 4. Adjustable Lancing Device Product Picture
Figure 5. Non-adjustable Lancing Device Product Picture
Figure 6. Global Diabetes Lancing Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Diabetes Lancing Devices Market Share by Application in 2023 & 2030
Figure 8. Household
Figure 9. Commercial
Figure 10. Global Diabetes Lancing Devices Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Diabetes Lancing Devices Market Size (2019-2030) & (US$ Million)
Figure 12. Global Diabetes Lancing Devices Sales (2019-2030) & (K Units)
Figure 13. Global Diabetes Lancing Devices Average Price (US$/Unit) & (2019-2030)
Figure 14. Diabetes Lancing Devices Report Years Considered
Figure 15. Diabetes Lancing Devices Sales Share by Manufacturers in 2023
Figure 16. Global Diabetes Lancing Devices Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Diabetes Lancing Devices Players: Market Share by Revenue in 2023
Figure 18. Diabetes Lancing Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Diabetes Lancing Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Diabetes Lancing Devices Sales Market Share by Country (2019-2030)
Figure 21. North America Diabetes Lancing Devices Revenue Market Share by Country (2019-2030)
Figure 22. United States Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Diabetes Lancing Devices Sales Market Share by Country (2019-2030)
Figure 25. Europe Diabetes Lancing Devices Revenue Market Share by Country (2019-2030)
Figure 26. Germany Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Diabetes Lancing Devices Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Diabetes Lancing Devices Revenue Market Share by Region (2019-2030)
Figure 33. China Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Diabetes Lancing Devices Sales Market Share by Country (2019-2030)
Figure 43. Latin America Diabetes Lancing Devices Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Diabetes Lancing Devices Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Diabetes Lancing Devices Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Diabetes Lancing Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Diabetes Lancing Devices by Type (2019-2030)
Figure 53. Global Revenue Market Share of Diabetes Lancing Devices by Type (2019-2030)
Figure 54. Global Diabetes Lancing Devices Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Diabetes Lancing Devices by Application (2019-2030)
Figure 56. Global Revenue Market Share of Diabetes Lancing Devices by Application (2019-2030)
Figure 57. Global Diabetes Lancing Devices Price (US$/Unit) by Application (2019-2030)
Figure 58. Diabetes Lancing Devices Value Chain
Figure 59. Diabetes Lancing Devices Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
